COP — CompuGroup Medical SE & Co KgaA Cashflow Statement
0.000.00%
- €1.14bn
- €1.91bn
- €1.15bn
- 79
- 35
- 69
- 68
Annual cashflow statement for CompuGroup Medical SE & Co KgaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 73.4 | 69 | 74.1 | 46.9 | 34.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 6.64 | -14.2 | 1.41 | 41.2 | -31.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -12.1 | 4.38 | -43.2 | -9.09 | 16 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 150 | 165 | 145 | 180 | 129 |
Capital Expenditures | -55.7 | -71.4 | -76.4 | -67.9 | -62.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -401 | -92.5 | -69 | -56.5 | -42.4 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Cash from Investing Activities | -457 | -164 | -145 | -124 | -105 |
Financing Cash Flow Items | -0.562 | -0.179 | -0.192 | -4.54 | -2.72 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 338 | 30.2 | -16.4 | -80.7 | 18.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 29.6 | 31.4 | -16.8 | -26.1 | 42.9 |